AbbVie (NYSE: ABBV), a global biopharmaceutical company, today announced promising results from CELEST, a Phase 2, randomized, double-blind, placebo-controlled study evaluating upadacitinib...

A new study finds that individuals struggling with obesity who are not candidates for weight-loss surgery can benefit substantially from non-surgical endoscopic sleeve gastroplasty (ESG),...

Mi9 Retail is pleased to announce that the agenda for the Synergy 2017 customer conference is now available on the Mi9 Retail web site. This year's event is taking place on September 12-15 at the...

Taking great ideas and turning them into reality will be the focus of the keynote speech at ChannelCon 2017, the information technology (IT) channel's premier education, networking and partnering...

Mark Martin, Director, Payer and Vendor Portfolio at Availity, the nation's largest real-time health information network, will take part in a panel discussion titled "Solving the Inaccuracy and...